185 related articles for article (PubMed ID: 24949636)
1. Proteomics analysis of the non-muscle myosin heavy chain IIa-enriched actin-myosin complex reveals multiple functions within the podocyte.
Hays T; Ma'ayan A; Clark NR; Tan CM; Teixeira A; Teixeira A; Choi JW; Burdis N; Jung SY; Bajaj AO; O'Malley BW; He JC; Hyink DP; Klotman PE
PLoS One; 2014; 9(6):e100660. PubMed ID: 24949636
[TBL] [Abstract][Full Text] [Related]
2. Plasma from a case of recurrent idiopathic FSGS perturbs non-muscle myosin IIA (MYH9 protein) in human podocytes.
Babayeva S; Miller M; Zilber Y; El Kares R; Bernard C; Bitzan M; Goodyer P; Torban E
Pediatr Nephrol; 2011 Jul; 26(7):1071-81. PubMed ID: 21380797
[TBL] [Abstract][Full Text] [Related]
3. Non-muscle myosin-IIA is critical for podocyte f-actin organization, contractility, and attenuation of cell motility.
Bondzie PA; Chen HA; Cao MZ; Tomolonis JA; He F; Pollak MR; Henderson JM
Cytoskeleton (Hoboken); 2016 Aug; 73(8):377-95. PubMed ID: 27232264
[TBL] [Abstract][Full Text] [Related]
4. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II-mediated MYH9 downregulation causes structural and functional podocyte injury in diabetic kidney disease.
Kang JS; Lee SJ; Lee JH; Kim JH; Son SS; Cha SK; Lee ES; Chung CH; Lee EY
Sci Rep; 2019 May; 9(1):7679. PubMed ID: 31118506
[TBL] [Abstract][Full Text] [Related]
6. Glomerular MYH9 expression is reduced by HIV-1.
Hays T; D'Agati VD; Garellek JA; Warren T; Trubin ME; Hyink DP; He JC; Klotman PE
AIDS; 2012 Apr; 26(7):797-803. PubMed ID: 22313957
[TBL] [Abstract][Full Text] [Related]
7. Nef interaction with actin compromises human podocyte actin cytoskeletal integrity.
Tan R; Patni H; Tandon P; Luan L; Sharma B; Salhan D; Saleem MA; Mathieson PW; Malhotra A; Husain M; Upadhya P; Singhal PC
Exp Mol Pathol; 2013 Feb; 94(1):51-7. PubMed ID: 22721673
[TBL] [Abstract][Full Text] [Related]
8. Expression of non-muscle type myosin heavy polypeptide 9 (MYH9) in mammalian cells.
Takubo T; Wakui S; Daigo K; Kurokata K; Ohashi T; Katayama K; Hino M
Eur J Histochem; 2003; 47(4):345-52. PubMed ID: 14706930
[TBL] [Abstract][Full Text] [Related]
9. Identification of a putative network of actin-associated cytoskeletal proteins in glomerular podocytes defined by co-purified mRNAs.
Nabet B; Tsai A; Tobias JW; Carstens RP
PLoS One; 2009 Aug; 4(8):e6491. PubMed ID: 19652713
[TBL] [Abstract][Full Text] [Related]
10.
Cechova S; Dong F; Chan F; Kelley MJ; Ruiz P; Le TH
J Am Soc Nephrol; 2018 Jan; 29(1):155-167. PubMed ID: 28993503
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 Nef disrupts the podocyte actin cytoskeleton by interacting with diaphanous interacting protein.
Lu TC; He JC; Wang ZH; Feng X; Fukumi-Tominaga T; Chen N; Xu J; Iyengar R; Klotman PE
J Biol Chem; 2008 Mar; 283(13):8173-82. PubMed ID: 18234668
[TBL] [Abstract][Full Text] [Related]
12. Non-muscle myosin heavy chain IIA and IIB interact and co-localize in living cells: relevance for MYH9-related disease.
Marini M; Bruschi M; Pecci A; Romagnoli R; Musante L; Candiano G; Ghiggeri GM; Balduini C; Seri M; Ravazzolo R
Int J Mol Med; 2006 May; 17(5):729-36. PubMed ID: 16596254
[TBL] [Abstract][Full Text] [Related]
13. Planar cell polarity pathway regulates actin rearrangement, cell shape, motility, and nephrin distribution in podocytes.
Babayeva S; Zilber Y; Torban E
Am J Physiol Renal Physiol; 2011 Feb; 300(2):F549-60. PubMed ID: 20534871
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor receptor 2 direct interaction with nephrin links VEGF-A signals to actin in kidney podocytes.
Bertuccio C; Veron D; Aggarwal PK; Holzman L; Tufro A
J Biol Chem; 2011 Nov; 286(46):39933-44. PubMed ID: 21937443
[TBL] [Abstract][Full Text] [Related]
15. Signaling via the angiotensin-converting enzyme results in the phosphorylation of the nonmuscle myosin heavy chain IIA.
Kohlstedt K; Kellner R; Busse R; Fleming I
Mol Pharmacol; 2006 Jan; 69(1):19-26. PubMed ID: 16186248
[TBL] [Abstract][Full Text] [Related]
16. Nonmuscle myosin IIA is required for lamellipodia formation through binding to WAVE2 and phosphatidylinositol 3,4,5-triphosphate.
Morimura S; Suzuki K; Takahashi K
Biochem Biophys Res Commun; 2011 Jan; 404(3):834-40. PubMed ID: 21184743
[TBL] [Abstract][Full Text] [Related]
17. Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton.
Faul C; Asanuma K; Yanagida-Asanuma E; Kim K; Mundel P
Trends Cell Biol; 2007 Sep; 17(9):428-37. PubMed ID: 17804239
[TBL] [Abstract][Full Text] [Related]
18. Myosin IIA is critical for organelle distribution and F-actin organization in megakaryocytes and platelets.
Pertuy F; Eckly A; Weber J; Proamer F; Rinckel JY; Lanza F; Gachet C; Léon C
Blood; 2014 Feb; 123(8):1261-9. PubMed ID: 24243973
[TBL] [Abstract][Full Text] [Related]
19. Of mice and men: Relevance of cellular and molecular characterizations of myosin IIA to MYH9-related human disease.
Even-Ram S; Yamada KM
Cell Adh Migr; 2007; 1(3):152-5. PubMed ID: 19262128
[TBL] [Abstract][Full Text] [Related]
20. MYH9-siRNA and MYH9 mutant alleles: expression in cultured cell lines and their effects upon cell structure and function.
Li Y; Friedmann DR; Mhatre AN; Lalwani AK
Cell Motil Cytoskeleton; 2008 May; 65(5):393-405. PubMed ID: 18330899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
